Mayne Pharma International Pty Ltd
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Mayne Pharma International Pty Ltd. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| INTI | Other | 2,240,488 | — | — | Jan 15, 2021 | |
| INTI | Other | 3,189,688 | — | — | Jul 15, 2020 | |
| INTI | Other | 362,121 | — | — | Jan 15, 2019 | |
| INTI | Purchase | 600,000 | $162,660.00 | $97,596,000,000 | Dec 19, 2017 | |
| INTI | X | 4,750,569 | — | — | Nov 15, 2016 | |
| INTI | X | 33,333,000 | — | — | Nov 4, 2016 | |
| INTI | Award / Grant | 33,333,333 | — | — | May 15, 2015 |